(Q46689580)

English

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

progesterone-receptor negative breast cancer

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Rachel Schiff

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

author name string

Grazia Arpino

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Heidi Weiss

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Adrian V Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Sabino De Placido

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

C Kent Osborne

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Richard M Elledge

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

97

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

17

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

1254-1261

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

Specific progesterone receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Reporter gene assay demonstrates functional differences in estrogen receptor activity in purified breast cancer cells: A pilot study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity i

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

A mechanism of drug resistance to tamoxifen in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

S-phase fraction and breast cancer--a decade of experience

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Growth factors. Clinical implications in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI249

21 January 2018

Identifiers

10.1093/JNCI/DJI249

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16145046

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46689580&oldid=2126849516"